Syncona Limited

BACT

GG00B8P59C08

Investment Holding Companies

Market Closed - London S.E. Other stock markets 11:35:29 2024-04-19 am EDT			5-day change	1st Jan Change
121.4 ^GBX	-1.62%		-0.16%	-1.62%

Apr. 11	Syncona agrees to sell stake in investee company for GBP7.4 million	AN
Apr. 11	Syncona to Sell Stake in Portfolio Company to Century Therapeutics	MT

BACIT : Monthly Factsheet - August 2016

September 26, 2016 at 11:41 am EDT

                                     BACIT Limited                                 
     (a closed-ended collective investment scheme established as a company with a  
     limited liability under the laws of Guernsey with registration number 55514)  

                                  Monthly Fact Sheet                               
                                      August 2016                                  

    Attached is a link to the August 2016 Monthly Fact Sheet for BACIT Limited.



    http://content.prnewswire.com/documents/
    PRNUK-2609161637-9678_BACIT_Factsheet_August_2016_CC.pdf



    Enquiries:
    Fraser Hiddelston
    Northern Trust International Fund Administration Services (Guernsey) Limited
    Tel: +44 (0) 1481 745738

Latest news about Syncona Limited

Syncona agrees to sell stake in investee company for GBP7.4 million	Apr. 11	AN
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	Apr. 11	MT
Syncona notes investee Achilles's annual loss narrows	Apr. 04	AN
Syncona portfolio company Autolus posts widened loss for 2023	Mar. 14	AN
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	Feb. 20	MT
Freeline shareholders approve Syncona acquisition	Feb. 12	AN
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	Feb. 12	MT
Syncona portfolio strengthens in third quarter thanks to Autolus	Feb. 08	AN
Syncona's Fiscal Q3 NAV Declines	Feb. 08	MT
Tranche Update on Syncona Limited's Equity Buyback Plan announced on September 29, 2023.	Feb. 08	CI
Syncona notes FDA acceptance of Autolus's BLA for obe-cel	Jan. 22	AN
Syncona says Freeline trial for Gaucher disease treatment positive	Jan. 19	AN
Syncona notes Beacon's "encouraging" AGTC-501 trial data	Dec. 04	AN
Molten Ventures completes raise; Saietta proposes one	Nov. 27	AN
Sector Update: Health Care Stocks Advance Late Afternoon	Nov. 22	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	Nov. 22	MT
FTSE 100 Closes Down 0.17% After Autumn Statement	Nov. 22	DJ
Syncona agrees to buyout deal with Freeline Therapeutics	Nov. 22	AN
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	Nov. 22	MT
Sector Update: Health Care	Nov. 22	MT
Syncona to Take Over Freeline Therapeutics	Nov. 22	MT
Freeline Therapeutics to be Acquired by Syncona for $28.3 Million	Nov. 22	MT
Syncona reports declining asset value as investment head steps down	Nov. 16	AN
Transcript : Syncona Limited, Q2 2024 Earnings Call, Nov 16, 2023	Nov. 16
Syncona Swings to Fiscal H1 Loss; Invest Income Falls	Nov. 16	MT

Syncona Limited is a Guernsey-based closed-ended investment company. The Companyâs investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership) in which the Company is the sole limited partner. The general partner of the Partnership is Syncona GP Limited (the General Partner), a wholly owned subsidiary of the Company. Syncona Investment Management Limited is its alternative investment manager.

Sector

Investment Holding Companies

Calendar

2024-06-20 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.214 GBP

Average target price

2.453 GBP

Spread / Average Target

+102.09%

Consensus

Sector Other Holding Companies

	1st Jan change	Capi.
SYNCONA LIMITED	-1.62%	985M
INVESTOR AB	+12.48%	73.22B
KOÇ HOLDING	+55.08%	17.11B
INVESTMENT AB LATOUR	+4.88%	16.12B
AB INDUSTRIVÄRDEN	+7.45%	13.97B
L E LUNDBERGFÖRETAGEN AB	-1.59%	12.26B
HAL TRUST	+10.19%	12.08B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+2.07%	10.45B
MERITZ FINANCIAL GROUP INC.	+26.90%	9.79B
GROUPE BRUXELLES LAMBERT SA	-2.13%	9.65B

Other Holding Companies

Syncona Limited

Equities

BACT

GG00B8P59C08

Investment Holding Companies

BACIT : Monthly Factsheet - August 2016

Latest news about Syncona Limited

Chart Syncona Limited

Company Profile

Income Statement Evolution

Analysts' Consensus

Sector Other Holding Companies